Wuhan Hvsen Biotechnology Co Ltd (300871) — Strategic Asset Allocation Index
Wuhan Hvsen Biotechnology Co Ltd (300871) has a Strategic Asset Allocation Index of 100.2% as of June 2023. Strategic assets (PP&E of CN¥1.51 Billion plus long-term investments of CN¥-) total CN¥1.51 Billion, measured against net assets of CN¥1.51 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 300871 net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Wuhan Hvsen Biotechnology Co Ltd Strategic Asset Allocation Index (2016–2022)
This chart shows how Wuhan Hvsen Biotechnology Co Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 100.2%, representing strategic assets of CN¥1.51 Billion against net assets of CN¥1.51 Billion CNY. For live market cap and overall valuation, see Wuhan Hvsen Biotechnology Co Ltd market capitalisation.
Annual Strategic Asset Allocation Index for Wuhan Hvsen Biotechnology Co Ltd (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Wuhan Hvsen Biotechnology Co Ltd from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Wuhan Hvsen Biotechnology Co Ltd's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 97.2% | CN¥1.50 Billion | CN¥1.50 Billion | CN¥- | CN¥1.54 Billion | ▲ +35.0 pp |
| 2021 | 62.2% | CN¥1.01 Billion | CN¥1.01 Billion | CN¥- | CN¥1.62 Billion | ▲ +32.3 pp |
| 2020 | 29.9% | CN¥412.33 Million | CN¥412.33 Million | CN¥- | CN¥1.38 Billion | ▼ -31.8 pp |
| 2019 | 61.7% | CN¥233.31 Million | CN¥233.31 Million | CN¥- | CN¥378.28 Million | ▲ +26.4 pp |
| 2018 | 35.2% | CN¥114.37 Million | CN¥114.37 Million | CN¥- | CN¥324.52 Million | ▼ -8.9 pp |
| 2017 | 44.1% | CN¥98.45 Million | CN¥98.45 Million | CN¥- | CN¥223.11 Million | ▼ -13.0 pp |
| 2016 | 57.1% | CN¥88.35 Million | CN¥88.35 Million | CN¥- | CN¥154.70 Million | — |